Abstract:BACKGROUND:Epithelial-to-mesenchymal transition (EMT) is involved in pathogenesis of human benign prostatic hyperplasia (BPH). Estrogenic signaling pathways may stimulate the induction of EMT. However, the details of estradiol (E2) and estrogen receptors (ERs) effects on EMT, as well as E2-induced modulation of benign prostatic epithelial cell phenotype in vitro have not been completely clarified. METHODS:The effects of E2 on EMT markers and cytokeratins (CKs) expression were evaluated in benign epithelial cell lines BPH-1 and RWPE-1, which were cultured both in two-dimensional (2D) culture and three-dimensional (3D) culture model using hanging drop technique or 3D Matrigel model. ER antagonist, ICI182,780, was used to confirm the regulatory effects of E2 on EMT and phenotypic modulation. In 3D culture, immunohistochemical stainings were performed to detect the specific phenotype of cells that underwent EMT in acinar-like spheroids formed by RWPE-1. To illustrate the exact function of ERs in E2-induced EMT and phenotypic modulation, specific short interfering RNAs (siRNAs), and agonists were used to knockdown or activate individual ERs, respectively. RESULTS:E2-induced EMT was observed both in 2D and 3D culture, with related regulation of EMT markers expression at both mRNA and protein level. In addition, E2 down-regulated luminal cell type markers CK18 and CK8 and up-regulated basal cell type markers CK5 and CK14. E2 also increased intermediate type markers CK15 and CK17, while it attenuated CK19 in 3D culture. ICI182,780 blocked E2-induced EMT and cell phenotypic switching. In 3D Matrigel culture, Vimentin was co-expressed with ERα and CK17, as well as with SMemb, which is related to cell status switching and proliferation. Knockdown of ERα but not GPR30 inhibited EMT, while ERβ knockdown facilitated EMT process. Knockdown of ERα blocked E2-induced EMT both in RWPE-1 and BPH-1. MRNA expression of EMT markers was stimulated by ERα-specific agonist PPT and inhibited by ERβ-specific agonist DPN. CONCLUSIONS:Estrogenic effect mediated by ERα can promote EMT. E2 is also an inductive factor of cell phenotypic switching. Cell type modulation is associated with E2-induced EMT in benign prostatic epithelial cells. Taken together the results support a contribution of estrogens to the pathogenesis of BPH in elderly men.

Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

Prostaglandin E2 Mediates Up-regulation of ERRα Expression with BPH-1 Condition Medium in Prostatic Stromal Cells

Relationship between the Expression of Estrogen Receptor α and Basal Cell Dedifferentiation in Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.

Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.

The Proliferative Effect of Estradiol on Human Prostate Stromal Cells is Mediated Through Activation of ERK.

171β-Estradiol regulates the expression of Cyclin D1 via estrogen receptor alpha in prostatic smooth muscle cells

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.

GPR30 Promotes Prostate Stromal Cell Activation Via Suppression of ERα Expression and Its Downstream Signaling Pathway.

17Beta-Estradiol at Low Concentrations Acts Through Distinct Pathways in Normal Versus Benign Prostatic Hyperplasia-Derived Prostate Stromal Cells.

Up-regulation of MMP-2 Expression by Estradiol via TGFβ1 in Prostate Stromal Cells

Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.

[Expression of Estrogen Receptor Beta in Benign Prostatic Hyperplasia Complicated by Chronic Prostatitis].

Estrogen Receptor Alpha is Essential for the Proliferation of Prostatic Smooth Muscle Cells Stimulated by 17β‐estradiol and Insulin‐like Growth Factor 1

Estrogen Up-regulates the Proliferation of Prostatic Stroma Cells Through Rapid Activation of MAPK Pathway

[Estradiol Stimulates Proliferation of Prostatic Smooth Muscle Cells Via Estrogen Receptor Alpha and IGF1].

Both Nongenomic and Genomic Effects Are Involved in Estradiol's Enhancing the Phenotype of Smooth Muscle Cells in Cultured Prostate Stromal Cells.

Expression and Significance of Estrogen Receptor Α and Β in Prostate Cancer and Peri-Cancer Tissue

Regulation of Proliferation and Differentiation of Prostatic Stromal Cells by Oestradiol Through Prostatic Epithelial Cells in a Paracrine Manner